ARTICLE | Company News
Elan, Warner Chilcott cardiovascular news
May 3, 1999 7:00 AM UTC
ELN reacquired from WCRX all rights to an extended release nifedipine product and the product's filed ANDA. ELN paid a fee and is liable for milestone and royalty payments to WCRX. The product is a generic alternative to Adalat CC, a nifedipine calcium channel blocker to treat hypertension sold by Bayer Corp. (Pittsburgh, Penn). ...